Difficulty: Medium
Average Score: 72%
Practice
The irreversible MAO inhibitors have a very high risk of developing:
Correct answer
C
Rationale
In the context of pharmacology, irreversible MAO inhibitors such as phenelzine and tranylcypromine pose a high risk of developing hypertensive reactions to tyramine ingested in food. This is because these medications inhibit the enzyme monoamine oxidase (MAO), which normally breaks down tyramine in the body. When MAO is inhibited, tyramine levels can rise, leading to hypertensive crisis characterized by severe hypertension, headache, palpitations, and potentially fatal cardiovascular complications.
Option A, respiratory depression, is not typically associated with irreversible MAO inhibitors. Option B, cardiovascular collapse and CNS depression, while serious, are not the primary concern with these medications. Option D, potentially fatal agranulocytosis, is a rare but serious adverse effect associated with other drug classes like antithyroid medications, not specifically with irreversible MAO inhibitors.
Educationally, understanding the specific risks and side effects of different drug classes is crucial for healthcare professionals to make informed decisions about medication management. In the case of irreversible MAO inhibitors, recognizing the potential for hypertensive crises due to tyramine interactions is essential for safe prescribing and patient education.
Option A, respiratory depression, is not typically associated with irreversible MAO inhibitors. Option B, cardiovascular collapse and CNS depression, while serious, are not the primary concern with these medications. Option D, potentially fatal agranulocytosis, is a rare but serious adverse effect associated with other drug classes like antithyroid medications, not specifically with irreversible MAO inhibitors.
Educationally, understanding the specific risks and side effects of different drug classes is crucial for healthcare professionals to make informed decisions about medication management. In the case of irreversible MAO inhibitors, recognizing the potential for hypertensive crises due to tyramine interactions is essential for safe prescribing and patient education.